cureatr-x3
close
 

Cureatr Welcomes Rose Abraham, PharmD, as Director of Clinical Pharmacy Operations

Featured Image

AUGUST 24, 2020 – New York, NYCureatr, Inc., a comprehensive medication management (CMM) technology and services company, announces that Rose Abraham, PharmD, has joined the company as Director of Clinical Pharmacy Operations.

Since Cureatr’s shift in focus from secure messaging and clinical transition notifications to comprehensive medication management in 2019, the company has been deploying software and services to repair the $528 billion suboptimal medication management problem in the US1. To fulfill this mission, Cureatr leverages Meds 360°. This real-time visualization of accurate medication data captures not just what’s in a patient's electronic medical record, but what the patient has actually paid for via nationwide, real-time pharmacy benefit manager (PBM) claims and pharmacy cash transactions.

Cureatr also provides clinical interventions by board-certified clinical tele-pharmacists with accredited residency training. Powered by Meds 360°, this comprehensive medication management clinical service works as an extension of a care team, with Cureatr pharmacists virtually assessing patients, evaluating medication care plans, and enabling real-time monitoring of medication-taking behavior. This enables healthcare providers to respond quickly when new drugs might prove dangerous or when medication non-adherence may lead to patient harm. The addition of Dr. Abraham provides Cureatr with valuable expertise and leadership as the company expands its clinical tele-pharmacy services.

In her role as Director of Clinical Pharmacy Operations, Dr. Abraham will oversee all of Cureatr’s pharmacy operations, including planning, recruitment, organizing, supervision, and quality assurance activities. Dr. Abraham will also play a crucial role in further developing Cureatr’s clinical pharmacy strategy and supporting business development.

“I was attracted to Cureatr because of its ability to make a profound impact in patients’ lives and clinical outcomes,” said Dr. Abraham. “With Cureatr, pharmacists can practice at the top of their license and keep patients out of the hospital.”

“We are excited to add Dr. Abraham join the Cureatr team,” said Michael Ross, MD, MHA, Cureatr’s Chief Medical Officer. “To bring our tele-pharmacy services to the next level, we recognized the need to bring in an expert clinical pharmacist with a strong leadership background. With Dr. Abraham, we have filled that need.

Dr. Abraham has more than a decade of pharmacy experience, working as a clinical pharmacist in Maryland and New York where she focused on specialty pharmacy and care management via medication therapy management (MTM). Most recently, Dr. Abraham worked for Capsule, a healthcare technology business rebuilding the pharmacy from the inside out. She received her Doctorate in Pharmacy from Massachusetts College of Pharmacy and Health Sciences and is currently an Executive MBA Candidate at the Quantic School of Business and Technology, with an expected graduation year of 2021.

To hear more from Dr. Abraham on her new position, the growing value of tele-pharmacy, and Cureatr's role in addressing suboptimal medication management, read this interview.

References: IMS Health, New England Healthcare Institute, Express Scripts, American Heart Assn, Premara Blue Cross, National Institutes of Health Watanabe JH, Mcinnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother, 2018.

 

Comments:

Stay Connected

Cureatr COVID-19 Response

Topics:

Press Release